SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Thursday broker round-up UPDATE

Thu, 16th Oct 2014 08:57
Afren: Investec cuts target price from 195p to 120p and reiterates its hold recommendation.Amerisur Resources: Investec lowers target price from 75p to 65p and maintains a buy recommendation.Antofagasta: UBS upgrades from sell to neutral with a target price of 710p.ARM Holdings: Credit Suisse reduces target price from 1100p to 1000p reiterating an outperform rating.ASOS: Goldman Sachs reduces target price from 4300p to 3000p and keeps a buy recommendation.AVEVA: Jefferies upgrades from hold to buy with a target price of 1760p.Bank of Georgia: Numis upgrades from hold to buy with a target price of 2708p.Bellway: UBS ups target price from 1870p to 1910p keeping a buy recommendation.Bunzl: Investec upgrades from add to buy with a target price of 1685p.bwin.party: PeelHunt places its target price (prev.: 110p) under review, while keeping a hold recommendation.Cairn Energy: Investec ups target price from 245p to 260p and reiterates a buy recommendation.Circle Oil: Investec lowers target price from 70p to 60p maintaining a buy recommendation.Consort Medical: PeelHunt reduces target price from 1187p to 916p staying with its buy recommendation.Diageo: Numis reduces target price from 1900p to 1800p retaining its hold recommendation.e2v technologies: Investec lowers target price from 225p to 220p, while staying with its buy recommendation.Faroe Petroleum: Investec cuts target price from 145p to 115p retaining a hold recommendation.GAME Digital: Canaccord Genuity shifts target price from 300p to 308p and leaves its buy recommendation unchanged. Liberum Capital raises target price from 265p to 350p and keeps a buy recommendation.Genel Energy: Investec reduces target price from 1060p to 900p, while its hold recommendation is kept.GKN: Exane cuts target price from 360p to 340p, while upgrading to outperform.Henderson Group: JP Morgan cuts target price from 245p to 222p leaving its neutral rating unchanged.IMI: Exane reduces target price from 1200p to 1100p and reiterates an underperform rating.Ithaca Energy: Investec cuts target price from 175p to 140p staying with its buy recommendation.Lekoil: Investec initiates with a target price of 90p and a buy recommendation.Mears Group: Investec upgrades from add to buy with a target price of 520p.Ophir Energy: Investec cuts target price from 250p to 215p leaving its hold recommendation unchanged.Polymetal: RBC Capital ups target price from 600p to 625p retaining an outperform rating.Premier Oil: Investec initiates with a target price of 350p and a buy recommendation.Restaurant Group: Numis upgrades from add to buy.Rolls-Royce: Berenberg reduces target price from 1216p to 1160p retaining a buy recommendation.Rotork: Exane reduces target price from 2575p to 2300p and maintains an underperform rating.SABMiller: JP Morgan raises target price from 3470p to 3600p and maintains an overweight rating.Shire: Panmure Gordon reduces target price from 5300p to 4200p, while upgrading to buy.Smiths Group: Exane reduces target price from 1255p to 1160p leaving its neutral rating unchanged.SOCO International: Investec initiates with a target price of 350p and a hold recommendation.Spectris: Exane reduces target price from 2070p to 1740p and stays with its neutral rating.Spirax-Sarco Engineering: Exane reduces target price from 2600p to 2450p and stays with its underperform rating.Trinity Exploration: Investec reduces target price from 215p to 145p staying with its buy recommendation.Tullow Oil: Investec reduces target price from 800p to 545p and reiterates a hold recommendation.Vesuvius: Exane reduces target price from 510p to 440p retaining a neutral rating.Weir Group: Exane reduces target price from 2950p to 2400p keeping an outperform rating.Wentworth Resources: Investec moves target price from 65p to 75p keeping a buy recommendation.Whitbread: Numis upgrades from hold to add with a target price of 4500p.

Related News

PRESS: Activist calls on Bunzl to undertake buyback as snaps up stake
2 hours ago

PRESS: Activist calls on Bunzl to undertake buyback as snaps up stake

(Alliance News) - Bunzl PLC shares moved higher on Monday morning after Bloomberg reported that activist investor Elliott Investment Management LP has...

WINNERS & LOSERS: Mining and travel stocks soar as Iran deal hits oil
2 hours ago

WINNERS & LOSERS: Mining and travel stocks soar as Iran deal hits oil

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday.

LONDON BROKER RATINGS: Exane BNP raises Halma; Shore says 'buy' boohoo
3 hours ago

LONDON BROKER RATINGS: Exane BNP raises Halma; Shore says 'buy' boohoo

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.